Markie125,
the PTX ph2, breast cancer HER2 trial result is a great achievement based on T-cell tech but here at IMU we are one step ahead using B-cell tech. HerVaxx is targeting HER2 as well but IMU wants to show it can be applied to gastric cancer as well, not just breast cancer.
I think current IMU sp action is not achievement related, it is more funds doing the things for their clients and we need to see whether they are LT buying or off loading. It will be bumpy, no doubt about it, but long term direction is up. Bumpy means plenty of trading options to make some extra cash while holding a core to be covered for the unexpected upward moves.
What IMU could be excited about is PTX' work developing CAR-T tech, if so, we will see a move to either t/o, partner or merge. I could imagine a tech based on B-cell and CAR-T in addition to the OV tech.
What a great stock and way too undervalued, but that's the way it is here in OZ.
GLTA
General Discussion, page-115
-
- There are more pages in this discussion • 152 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
-0.001(1.89%) |
Mkt cap ! $382.1M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.4¢ | 5.2¢ | $216.1K | 4.106M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 1854997 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 382882 | 4 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |